Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leuprolide Acetate to Enhance Immune Function Post-Autologous Stem Cell Transplantation

NCT00275262 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00275262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00275262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leuprolide Acetate to Enhance Immune Function Post-Autologous Stem Cell Transplantation
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2006
Completion date
Not reported
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, lymphoma, non-hodgkin, mantle cell lymphoma, multiple myeloma